# Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma

> **NCT00006383** · PHASE2 · COMPLETED · sponsor: **Inex Pharmaceuticals**

## Conditions studied

- Lymphoma

## Interventions

- **DRUG:** liposomal vincristine sulfate

## Key facts

- **NCT ID:** NCT00006383
- **Lead sponsor:** Inex Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-06
- **Primary completion:** —
- **Final completion:** 2009-08
- **Target enrollment:** — (—)
- **Last updated:** 2013-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00006383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00006383, "Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00006383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*